David A. Braun

David A. Braun, MD, PhD, is an Assistant Professor of Medicine (Medical Oncology) at Yale School of Medicine and a member of the Center of Molecular and Cellular Oncology (CMCO) at Yale Cancer Center. He specializes in treating kidney cancers and integrates computational and experimental approaches to advance immunotherapy for renal cell carcinoma. His research focuses on tumor genetics, immune microenvironment dynamics, and T cell-antigen interactions to develop precision therapies.

Education & Training:

• MD: Icahn School of Medicine at Mount Sinai (2013)
• PhD: New York University (Computational Biology, 2012)
• Residency: Brigham and Women’s Hospital (2015)
• Fellowship: Dana-Farber Cancer Institute (2019)

Research Interests:

• Mechanisms of immune therapy response/resistance in kidney cancer
• Single-cell proteogenomics of tumor-immune interactions
• Identification of tumor antigens and TCR-peptide-MHC interactions

Awards:

• R37 MERIT Award (NIH/NCI, 2023)
• Idea Development Award (2023)
• Young Physician-Scientist Award (ASCI, 2023)

Lab & Collaborations: The BraunLab develops patient-derived models and spatial profiling tools to study tumor immunity. Collaborators include Michael Hurwitz, Talal El Zarif, and Sidi Chen (CRI CLIP Awardee co-recipient).